Cargando…
PCAT6 may be a new prognostic biomarker in various cancers: a meta-analysis and bioinformatics analysis
BACKGROUND: LncRNA prostate cancer-associated transcript 6 (PCAT6) has been reported to be dysregulated in several cancers and is associated with tumor progression. Here, we have performed a meta-analysis to assess the general prognostic role of PCAT6 in malignancies. METHODS: Four public databases...
Autores principales: | Shi, Song-bo, Cheng, Qing-hao, Gong, Shi-yi, Lu, Ting-ting, Guo, Shi-fang, Song, Shao-ming, Yang, Yu-ping, Cui, Qi, Yang, Ke-hu, Qian, Yao-wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273986/ https://www.ncbi.nlm.nih.gov/pubmed/34247605 http://dx.doi.org/10.1186/s12935-021-02079-4 |
Ejemplares similares
-
LINC00958 may be a new prognostic biomarker in various cancers: A meta-analysis and bioinformatics analysis
por: Zhang, Helin, et al.
Publicado: (2022) -
Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer()
por: Shukla, Sudhanshu, et al.
Publicado: (2016) -
PCAT6 May Be a Whistler and Checkpoint Target for Precision Therapy in Human Cancers
por: Jiang, Feng, et al.
Publicado: (2021) -
Prognostic potential of miR-144 in various cancers: A meta-analysis
por: Jia, Chong-Yang, et al.
Publicado: (2022) -
LncRNA HCP5 as a potential therapeutic target and prognostic biomarker for various cancers: a meta‑analysis and bioinformatics analysis
por: Hu, Shao-pu, et al.
Publicado: (2021)